Literature DB >> 25575119

Safety of MR Imaging at 1.5 T in Fetuses: A Retrospective Case-Control Study of Birth Weights and the Effects of Acoustic Noise.

Brigitte Strizek1, Jacques C Jani, Eugène Mucyo, Frederik De Keyzer, Inge Pauwels, Samir Ziane, Anne-Laure Mansbach, Paul Deltenre, Teresa Cos, Mieke M Cannie.   

Abstract

PURPOSE: To evaluate the effects of exposure to routine magnetic resonance (MR) imaging at 1.5 T during pregnancy on fetal growth and neonatal hearing function in relation to the dose and timing of in utero exposure in a group of newborns at low risk for congenital hearing impairment or deafness.
MATERIALS AND METHODS: This retrospective case-control study was approved by the local ethics committee, and written informed consent was waived. Between January 2008 and December 2012, a group of 751 neonates exposed to MR imaging in utero and a group of control subjects comprising 10 042 nonexposed neonates, both groups with no risk factors for hearing impairment at birth, were included. Neonatal hearing screening was performed by means of otoacoustic emission testing and auditory brain stem response according to national guidelines, and the prevalence of hearing impairment in the two groups was compared by using a noninferiority test with Wilson score confidence intervals. The effect of MR exposure on birth weight percentile was examined between the singleton neonates in the exposed group and a randomly chosen subset of 1805 singleton newborns of the nonexposed group by performing an analysis of variance.
RESULTS: The rate of hearing impairment or deafness was found to be 0% (0 of 751) in the neonates in the exposed group and was not inferior to that in the nonexposed group (34 of 10 042 [0.34%], P < .05). There was no between-group difference in birth weight percentiles (50.6% for exposed vs 48.4% for nonexposed; P = .22).
CONCLUSION: This study showed no adverse effects of exposure to 1.5-T MR imaging in utero on neonatal hearing function or birth weight percentiles. (©) RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25575119     DOI: 10.1148/radiol.14141382

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Fetal magnetic resonance imaging: exposure times and functional outcomes at preschool age.

Authors:  Marine Bouyssi-Kobar; Adré J du Plessis; Richard L Robertson; Catherine Limperopoulos
Journal:  Pediatr Radiol       Date:  2015-07-09

Review 2.  MRI in pregnant patients with suspected abdominal and pelvic cancer: a practical guide for radiologists.

Authors:  Benedetta Gui; Francesco Cambi; Maura Micco; Martina Sbarra; Federica Petta; Rosa Autorino; Rosa De Vincenzo; Vincenzo Valentini; Giovanni Scambia; Riccardo Manfredi
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

3.  The prenatal diagnosis and classification of cleft palate: the role and value of magnetic resonance imaging.

Authors:  Weizeng Zheng; Baohua Li; Yu Zou; Fenlan Lou
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 4.  Findings and differential diagnosis of fetal intracranial haemorrhage and fetal ischaemic brain injury: what is the role of fetal MRI?

Authors:  Bryn Putbrese; Anne Kennedy
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

Review 5.  Fetal Echoplanar Imaging: Promises and Challenges.

Authors:  Onur Afacan; Judy A Estroff; Edward Yang; Carol E Barnewolt; Susan A Connolly; Richard B Parad; Robert V Mulkern; Simon K Warfield; Ali Gholipour
Journal:  Top Magn Reson Imaging       Date:  2019-10

6.  Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.

Authors:  Sileny N Han; Frédéric Amant; Katrijn Michielsen; Frederik De Keyzer; Steffen Fieuws; Kristel Van Calsteren; Raphaëla C Dresen; Mina Mhallem Gziri; Vincent Vandecaveye
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

7.  Fetal Exposure to MR Imaging: Long-Term Neurodevelopmental Outcome.

Authors:  E Zvi; A Shemer; S Toussia-Cohen; D Zvi; Y Bashan; L Hirschfeld-Dicker; N Oselka; M-M Amitai; O Ezra; O Bar-Yosef; E Katorza
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

Review 8.  [Protection of the unborn child in diagnostic and interventional radiological procedures].

Authors:  A Hojreh; H Prosch; G Karanikas; P Homolka; S Trattnig
Journal:  Radiologe       Date:  2015-08       Impact factor: 0.635

Review 9.  Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Authors:  Karen G Ordovas; Lauren A Baldassarre; Chiara Bucciarelli-Ducci; James Carr; Juliano Lara Fernandes; Vanessa M Ferreira; Luba Frank; Sophie Mavrogeni; Ntobeko Ntusi; Ellen Ostenfeld; Purvi Parwani; Alessia Pepe; Subha V Raman; Hajime Sakuma; Jeanette Schulz-Menger; Lilia M Sierra-Galan; Anne Marie Valente; Monvadi B Srichai
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

10.  Effects of Gestational Magnetic Resonance Imaging on Methylation Status of Leptin Promoter in the Placenta and Cord Blood.

Authors:  Ying Wang; Feng-Shan Yan; Jian-Min Lian; She-Wei Dou
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.